About Careers Internship MedBlogs Contact us
Cholesterol-lowering Medication Could Reduce Risk of Typhoid

Cholesterol-lowering Medication Could Reduce Risk of Typhoid

Font : A-A+

  • The susceptibility to typhoid infection varies among individuals
  • Some people exposed to the infection do not suffer, from it while others develop symptoms
  • Scientists evaluated the possible link between a mutation in the VAC14 gene and the risk of typhoid infection

Cholesterol-lowering medications could possibly have effects that are totally unrelated to their intended use, which could be beneficial to the patient. New research published in the Proceedings of the National Academy of Sciences suggests that is possible that they protect against infections like typhoid!


Cholesterol-lowering medications reduce the risk of heart disease and stroke. They keep the blood cholesterol levels within normal limits, thus preventing its accumulation in the walls of arteries, which can block the flow of blood to vital organs.Statins like rosuvastatin and atorvastatin are the most popular; they prevent the synthesis of bad cholesterol by inhibiting the enzyme HMG CoA reductase, and are therefore, also called HMG CoA reductase inhibitors. Other cholesterol-lowering drugs include the bile acid binding agents cholestyramine, colestipol and colesevelam, the fibrates like gemfibrozil, niacin, the omega-3 fatty acid ethyl esters, and the selective cholesterol absorption inhibitor ezetimibe.

Typhoid is an infectious disease caused by the bacterium Salmonella typhi. It causes symptoms of high fever, stomach pain, and loss of appetite. Treatment is with specific antibiotics. In the absence of treatment, typhoid can result in complications like internal bleeding and perforation, and can be even fatal. Vaccination, including an oral vaccine, is available to prevent the infection.

People are variably susceptible to the Salmonella typhi; some people suffer from an infection when exposed to the S. typhi bacterium, while others may be totally unaffected. Scientists conducted a genome-wide study to find a possible genetic reason for this difference in susceptibility.

The scientists obtained cells from hundreds of healthy individuals and exposed them to typhoid bacteria tagged with a fluorescent marker. The marker enabled detection of the movement of the bacteria into the cells.

The scientists found that the cells that had a mutation in the VAC14 gene promoted the docking and entry of the Salmonella typhi bacterium into the cells. The cells with the mutation had high cholesterol levels in the plasma membrane. When the scientists knocked out the gene, more cells allowed the entry of the bacteria, thus confirming their findings.

The scientists took another step forward by treating a zebrafish with the cholesterol-lowering medication ezetimibe. Ezetimibe prevents the absorption of cholesterol from the intestines in human beings, thereby reducing its level in the body. The cholesterol in the intestine is obtained either from either dietary sources or is secreted into the intestine by the bile acids. The scientists added ezetimibe to the water around the fish and then injected the fish with the S. typhi bacteria. They found that the treated zebrafish were more likely to survive the typhoid infection.

Further research in this direction could possibly result in the development of medications that could prevent typhoid infection, which could be particularly useful in those regions where the infection is highly prevalent. This entails carrying out similar testing in mice, and with different bacteria to evaluate if the same mechanism can determine susceptibility to other infections as well.

Reference :
  1. Alvarez MI et al. "Human Genetic Variation in VAC14 Regulates Salmonella Invasion and Typhoid Fever through Modulation of Cholesterol," PNAS, doi: 10.1073/pnas.1706070114

Source: Medindia

Citations   close

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Simi Paknikar. (2017, August 22). Cholesterol-lowering Medication Could Reduce Risk of Typhoid. Medindia. Retrieved on May 26, 2022 from https://www.medindia.net/news/healthinfocus/cholesterol-lowering-medication-could-reduce-risk-of-typhoid-172472-1.htm.

  • MLA

    Simi Paknikar. "Cholesterol-lowering Medication Could Reduce Risk of Typhoid". Medindia. May 26, 2022. <https://www.medindia.net/news/healthinfocus/cholesterol-lowering-medication-could-reduce-risk-of-typhoid-172472-1.htm>.

  • Chicago

    Simi Paknikar. "Cholesterol-lowering Medication Could Reduce Risk of Typhoid". Medindia. https://www.medindia.net/news/healthinfocus/cholesterol-lowering-medication-could-reduce-risk-of-typhoid-172472-1.htm. (accessed May 26, 2022).

  • Harvard

    Simi Paknikar. 2021. Cholesterol-lowering Medication Could Reduce Risk of Typhoid. Medindia, viewed May 26, 2022, https://www.medindia.net/news/healthinfocus/cholesterol-lowering-medication-could-reduce-risk-of-typhoid-172472-1.htm.


News A-Z
What's New on Medindia
Monkeypox Outbreak: What it is, How Does it Spread & the Prevention
Seasonal Allergy Medications
How to Choose the Best Eczema-Friendly Moisturizer for Children?
View all
Recommended Reading
News Archive
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Typhoid and Paratyphoid Enteric Fevers Salmonellosis Healthy Living Fever Link between Statins and Vitamin D 

Most Popular on Medindia

How to Reduce School Bag Weight - Simple Tips Hearing Loss Calculator Drug - Food Interactions The Essence of Yoga Selfie Addiction Calculator Turmeric Powder - Health Benefits, Uses & Side Effects Nutam (400mg) (Piracetam) Daily Calorie Requirements Find a Doctor A-Z Drug Brands in India

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close